These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3155580)

  • 21. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
    Fauser AA; Shustik C; Langleben A; Laurent G; Kanz L; Spurll GM; Price G; Ahlgren PD; Cooper BA
    Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal antibodies in clinical diagnosis and therapy].
    Gramatzki M; Kalden JR
    Fortschr Med; 1985 Sep; 103(36):843-8. PubMed ID: 2934307
    [No Abstract]   [Full Text] [Related]  

  • 25. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of T-cell content in transplanted human bone marrow: effect on GVH and GVL reactions.
    Truitt RL; Ash RC
    Prog Clin Biol Res; 1987; 244():409-21. PubMed ID: 3310003
    [No Abstract]   [Full Text] [Related]  

  • 27. T cell depletion of human bone marrow for allogeneic marrow transplantation.
    Farrelly H; Cooley M; O'Flaherty E; Biggs J; Atkinson K
    Transplant Proc; 1987 Apr; 19(2):2855-7. PubMed ID: 3551227
    [No Abstract]   [Full Text] [Related]  

  • 28. Functional and morphological suppressor T cell deficit in acute GVHD.
    Di Padova F; Gratwohl A; Corneo M; Speck B
    Clin Exp Immunol; 1984 Dec; 58(3):611-8. PubMed ID: 6150776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subsets of T lymphocyte subpopulations after human marrow transplantation defined by monoclonal antibodies and two-color fluorescence.
    Farrell C; Atkinson K; Chapman G; Penny R; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1704-6. PubMed ID: 3885509
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F; Raffoux C; Griscelli C; Fischer A
    J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell regeneration after allogeneic bone marrow transplantation.
    Favrot M; Janossy G; Tidman N; Blacklock H; Lopez E; Bofill M; Lampert I; Morgenstein G; Powles R; Prentice HG
    Clin Exp Immunol; 1983 Oct; 54(1):59-72. PubMed ID: 6352107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in rectal leucocytes after allogeneic bone marrow transplantation.
    Dilly SA; Sloane JP
    Clin Exp Immunol; 1987 Jan; 67(1):151-8. PubMed ID: 3304737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological analysis of the skin in graft versus host disease.
    Lampert IA; Janossy G; Suitters AJ; Bofill M; Palmer S; Gordon-Smith E; Prentice HG; Thomas JA
    Clin Exp Immunol; 1982 Oct; 50(1):123-31. PubMed ID: 6756725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
    Merot Y; Gravallese E; Guillén FJ; Murphy GF
    Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.